<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Systemic scleroderma - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Systemic_scleroderma" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Systemic_scleroderma&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Systemic_scleroderma&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Systemic_scleroderma" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Systemic_scleroderma" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Systemic_scleroderma","wgTitle":"Systemic scleroderma","wgCurRevisionId":653035090,"wgRevisionId":653035090,"wgArticleId":26951,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 maint: Explicit use of et al.","CS1 German-language sources (de)","Articles with contributors link","All articles lacking reliable references","Articles lacking reliable references from November 2014","All articles with unsourced statements","Articles with unsourced statements from May 2008","Articles with limited geographic scope from May 2008","Articles that use a Medicine navs subtemplate","Mucinoses","Connective tissue diseases","Autoimmune diseases","Disorders of fascia","Systemic connective tissue disorders"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Systemic_scleroderma","wgRelevantArticleId":26951,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgRedirectedFrom":"Systemic_sclerosis","wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/c/c7/Systemic_sclerosis_finger.jpg/100px-Systemic_sclerosis_finger.jpg","wgULSAcceptLanguageList":["en-us"],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgInternalRedirectTargetUrl":"/wiki/Systemic_scleroderma","wgWikibaseItemId":"Q5340515"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.action.view.redirect","mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Systemic_scleroderma skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Systemic scleroderma</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"><span class="mw-redirectedfrom">  (Redirected from <a href="/w/index.php?title=Systemic_sclerosis&amp;redirect=no" title="Systemic sclerosis">Systemic sclerosis</a>)</span></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Systemic sclerosis</th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Systemic_sclerosis_finger.jpg" class="image"><img alt="Systemic sclerosis finger.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/c/c7/Systemic_sclerosis_finger.jpg/230px-Systemic_sclerosis_finger.jpg" width="230" height="153" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/c/c7/Systemic_sclerosis_finger.jpg/345px-Systemic_sclerosis_finger.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/c7/Systemic_sclerosis_finger.jpg/460px-Systemic_sclerosis_finger.jpg 2x" data-file-width="1772" data-file-height="1181" /></a>
<div>Clinical appearance of acrosclerotic piece-meal <a href="/wiki/Necrosis" title="Necrosis">necrosis</a> of the thumb in a patient with systemic sclerosis.</div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/M34">M34</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=710.1">710.1</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<td><a rel="nofollow" class="external text" href="http://omim.org/entry/181750">181750</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb12845.htm">12845</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/ency/article/000429.htm">000429</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://www.emedicine.com/derm/topic677.htm">derm/677</a> <a rel="nofollow" class="external text" href="http://www.emedicine.com/ped/topic2197.htm#">ped/2197</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a rel="nofollow" class="external text" href="//www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&amp;term=D012595">D012595</a></td>
</tr>
</table>
<p><b>Systemic sclerosis</b> or <b>systemic <a href="/wiki/Scleroderma(medicine)" title="Scleroderma(medicine)" class="mw-redirect">scleroderma</a></b> is an <a href="/wiki/Systemic_autoimmune_disease" title="Systemic autoimmune disease" class="mw-redirect">autoimmune</a> or <a href="/wiki/Connective_tissue_disease" title="Connective tissue disease">connective tissue disease</a>. It is characterized by thickening of the skin caused by accumulation of collagen, and by injuries to the smallest arteries. There are two overlapping forms. Limited cutaneous scleroderma is limited to the skin on the face, hands and feet. Diffuse cutaneous scleroderma covers more of the skin, and is at risk of progressing to the visceral organs, including the kidneys, heart, lungs and gastrointestinal tract.</p>
<p>Survival is determined by the severity of visceral disease. Prognosis is difficult to predict until the disease differentiates into recognizable subsets. Patients with limited cutaneous scleroderma have a good prognosis, with 10-year survival of 75%, although &lt;10% develop <a href="/wiki/Pulmonary_hypertension" title="Pulmonary hypertension">pulmonary arterial hypertension</a> after 10 to 20 years. Patients with diffuse cutaneous scleroderma have a 10-year survival of 55%. Death is most often from pulmonary, heart and kidney involvement, although survival has greatly improved with effective treatment for kidney failure. Immunosuppressive drugs are used, although glucocorticoids have limited application.<sup id="cite_ref-Harrison.27s_1-0" class="reference"><a href="#cite_note-Harrison.27s-1"><span>[</span>1<span>]</span></a></sup></p>
<p>Annual incidence is 19 per million, and prevalence is 19-75 per 100,000, with a female:male ratio of 3:1, and 8:1 in mid to late childbearing years. Incidence is twice as high among African Americans, and the Choctaw Native Americans in Oklahoma have the highest prevalence in the world (469/100,000). There is some hereditary association, some suggestion of immune reaction (molecular mimicry) to a virus, and some cases caused by toxins.<sup id="cite_ref-Harrison.27s_1-1" class="reference"><a href="#cite_note-Harrison.27s-1"><span>[</span>1<span>]</span></a></sup></p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#Skin_symptoms"><span class="tocnumber">1.1</span> <span class="toctext">Skin symptoms</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Other_organs"><span class="tocnumber">1.2</span> <span class="toctext">Other organs</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-4"><a href="#Diagnosis"><span class="tocnumber">2</span> <span class="toctext">Diagnosis</span></a></li>
<li class="toclevel-1 tocsection-5"><a href="#Causes"><span class="tocnumber">3</span> <span class="toctext">Causes</span></a></li>
<li class="toclevel-1 tocsection-6"><a href="#Pathophysiology"><span class="tocnumber">4</span> <span class="toctext">Pathophysiology</span></a></li>
<li class="toclevel-1 tocsection-7"><a href="#Therapy"><span class="tocnumber">5</span> <span class="toctext">Therapy</span></a>
<ul>
<li class="toclevel-2 tocsection-8"><a href="#Topical.2Fsymptomatic"><span class="tocnumber">5.1</span> <span class="toctext">Topical/symptomatic</span></a></li>
<li class="toclevel-2 tocsection-9"><a href="#Kidney_disease"><span class="tocnumber">5.2</span> <span class="toctext">Kidney disease</span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#Lung_disease_and_pulmonary_hypertension"><span class="tocnumber">5.3</span> <span class="toctext">Lung disease and pulmonary hypertension</span></a></li>
<li class="toclevel-2 tocsection-11"><a href="#Experimental_treatments"><span class="tocnumber">5.4</span> <span class="toctext">Experimental treatments</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-12"><a href="#Epidemiology"><span class="tocnumber">6</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1 tocsection-13"><a href="#Advocacy"><span class="tocnumber">7</span> <span class="toctext">Advocacy</span></a></li>
<li class="toclevel-1 tocsection-14"><a href="#References"><span class="tocnumber">8</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-15"><a href="#External_links"><span class="tocnumber">9</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Systemic_scleroderma&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p><i>Diffuse Scleroderma</i> - affects the skin as well as the heart, lungs, GI tract, and kidneys.</p>
<p><i>Limited Scleroderma</i> - mostly affects the skin of the face, neck and distal elbows and knees and late in the disease causes isolated pulmonary hypertension. CREST syndrome (Calcinosis, Raynaud's phenomenon, Esophageal dysfunction, Sclerodactyly, Telangiectasias) is associated with limited scleroderma.</p>
<p>There is a slight increase in the risk of cancer with systemic sclerosis.<sup id="cite_ref-2" class="reference"><a href="#cite_note-2"><span>[</span>2<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Skin_symptoms">Skin symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Systemic_scleroderma&amp;action=edit&amp;section=2" title="Edit section: Skin symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In the <a href="/wiki/Human_skin" title="Human skin">skin</a>, systemic sclerosis causes hardening and scarring. The skin may appear tight, reddish or scaly. Blood vessels may also be more visible. Where large areas are affected, fat and muscle wastage may weaken limbs and affect appearance. Also, patients report substantial, even severe and recurrent <a href="/wiki/Itch" title="Itch">itching</a> of large skin areas, the source of much affliction as the condition worsens. There is much variation in severity between patients, with some having scleroderma of only a limited area of the skin (such as the fingers) and little involvement of the underlying tissue; while others have progressive skin involvement.<sup id="cite_ref-3" class="reference"><a href="#cite_note-3"><span>[</span>3<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Other_organs">Other organs</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Systemic_scleroderma&amp;action=edit&amp;section=3" title="Edit section: Other organs">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Diffuse scleroderma can cause <a href="/wiki/Musculoskeletal_system" title="Musculoskeletal system" class="mw-redirect">musculoskeletal</a>, <a href="/wiki/Lung" title="Lung">pulmonary</a>, <a href="/wiki/Gastrointestinal_tract" title="Gastrointestinal tract" class="mw-redirect">gastrointestinal</a>, <a href="/wiki/Kidney" title="Kidney">renal</a> and other complications.<sup id="cite_ref-Primer_4-0" class="reference"><a href="#cite_note-Primer-4"><span>[</span>4<span>]</span></a></sup> Patients with larger amounts of cutaneous involvement are more likely to have involvement of the internal tissues and organs. Most patients (over 80%) have vascular symptoms and <a href="/wiki/Raynaud%27s_phenomenon" title="Raynaud's phenomenon">Raynaud's phenomenon</a>, which leads to attacks of discoloration of the hands and feet in response to cold. Raynaud's normally affects the <a href="/wiki/Finger" title="Finger">fingers</a> and toes. Systemic scleroderma and Raynaud's can cause painful ulcers on the fingers or toes which are known as digital ulcers. <a href="/wiki/Calcinosis" title="Calcinosis">Calcinosis</a> (deposition of calcium in lumps under the skin) is also common in systemic scleroderma, and is often seen near the elbows, knees or other <a href="/wiki/Joints" title="Joints" class="mw-redirect">joints</a>.</p>
<dl>
<dt>Musculoskeletal</dt>
</dl>
<p>The first joint symptoms that patients with scleroderma have are typically non specific <a href="/wiki/Arthralgia" title="Arthralgia">joint pains</a>, which can lead to <a href="/wiki/Arthritis" title="Arthritis">arthritis</a>, or cause discomfort in <a href="/wiki/Tenosynovitis" title="Tenosynovitis">tendons</a> or <a href="/wiki/Myalgia" title="Myalgia">muscles</a>.<sup id="cite_ref-Primer_4-1" class="reference"><a href="#cite_note-Primer-4"><span>[</span>4<span>]</span></a></sup> Joint mobility, especially of the small joints of the hand, may be restricted by <a href="/wiki/Calcinosis" title="Calcinosis">calcinosis</a> or skin thickening.<sup id="cite_ref-5" class="reference"><a href="#cite_note-5"><span>[</span>5<span>]</span></a></sup> Patients may develop muscle weakness, or <a href="/wiki/Myopathy" title="Myopathy">myopathy</a>, either from the disease, or its treatments.<sup id="cite_ref-6" class="reference"><a href="#cite_note-6"><span>[</span>6<span>]</span></a></sup></p>
<dl>
<dt>Lungs</dt>
</dl>
<p>Some impairment in lung function is almost universally seen in patients with diffuse scleroderma on <a href="/wiki/Pulmonary_function_test" title="Pulmonary function test" class="mw-redirect">pulmonary function testing</a>;<sup id="cite_ref-7" class="reference"><a href="#cite_note-7"><span>[</span>7<span>]</span></a></sup> however, it does not necessarily cause symptoms, such as shortness of breath. Some patients can develop <a href="/wiki/Pulmonary_hypertension" title="Pulmonary hypertension">pulmonary hypertension</a>, or elevation in the pressures of the <a href="/wiki/Pulmonary_arteries" title="Pulmonary arteries" class="mw-redirect">pulmonary arteries</a>. This can be progressive, and lead to right sided <a href="/wiki/Heart_failure" title="Heart failure">heart failure</a>. The earliest manifestation of this may be a decreased <a href="/wiki/Diffusion_capacity" title="Diffusion capacity" class="mw-redirect">diffusion capacity</a> on pulmonary function testing.</p>
<p>Other pulmonary complications in more advanced disease include <a href="/wiki/Aspiration_pneumonia" title="Aspiration pneumonia">aspiration pneumonia</a>, <a href="/wiki/Pulmonary_hemorrhage" title="Pulmonary hemorrhage">pulmonary hemorrhage</a> and <a href="/wiki/Pneumothorax" title="Pneumothorax">pneumothorax</a>.<sup id="cite_ref-Primer_4-2" class="reference"><a href="#cite_note-Primer-4"><span>[</span>4<span>]</span></a></sup></p>
<dl>
<dt>Digestive tract</dt>
</dl>
<div class="thumb tright">
<div class="thumbinner" style="width:202px;"><a href="/wiki/File:Peptic_stricture.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/16/Peptic_stricture.png/200px-Peptic_stricture.png" width="200" height="195" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/16/Peptic_stricture.png/300px-Peptic_stricture.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/16/Peptic_stricture.png/400px-Peptic_stricture.png 2x" data-file-width="460" data-file-height="448" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Peptic_stricture.png" class="internal" title="Enlarge"></a></div>
<a href="/wiki/Gastroscopy" title="Gastroscopy" class="mw-redirect">Endoscopic</a> image of peptic stricture, or narrowing of the <a href="/wiki/Esophagus" title="Esophagus">esophagus</a> near the junction with the <a href="/wiki/Stomach" title="Stomach">stomach</a> due to chronic <a href="/wiki/Gastroesophageal_reflux" title="Gastroesophageal reflux" class="mw-redirect">gastroesophageal reflux</a>. This is the most common cause of <a href="/wiki/Dysphagia" title="Dysphagia">dysphagia</a>, or difficulty swallowing, in scleroderma.</div>
</div>
</div>
<p>Diffuse scleroderma can affect any part of the gastrointestinal tract.<sup id="cite_ref-Sallam_8-0" class="reference"><a href="#cite_note-Sallam-8"><span>[</span>8<span>]</span></a></sup> The most common manifestation in the <a href="/wiki/Esophagus" title="Esophagus">esophagus</a> is <a href="/wiki/Esophagitis" title="Esophagitis">reflux esophagitis</a>, which may be complicated by <a href="/w/index.php?title=Peptic_stricture&amp;action=edit&amp;redlink=1" class="new" title="Peptic stricture (page does not exist)">peptic stricturing</a>, or benign narrowing of the esophagus.<sup id="cite_ref-Rose_9-0" class="reference"><a href="#cite_note-Rose-9"><span>[</span>9<span>]</span></a></sup> This is best initially treated with <a href="/wiki/Proton_pump_inhibitor" title="Proton pump inhibitor" class="mw-redirect">proton pump inhibitors</a> for acid suppression,<sup id="cite_ref-10" class="reference"><a href="#cite_note-10"><span>[</span>10<span>]</span></a></sup> but may require <a href="/wiki/Esophageal_dilatation" title="Esophageal dilatation">bougie dilatation</a> in the case of stricture.<sup id="cite_ref-Sallam_8-1" class="reference"><a href="#cite_note-Sallam-8"><span>[</span>8<span>]</span></a></sup></p>
<p>Scleroderma can decrease <a href="/wiki/Motility" title="Motility">motility</a> anywhere in the gastrointestinal tract.<sup id="cite_ref-Sallam_8-2" class="reference"><a href="#cite_note-Sallam-8"><span>[</span>8<span>]</span></a></sup> The most common source of decreased motility involvement is the esophagus and the lower esophageal sphincter, leading to <a href="/wiki/Dysphagia" title="Dysphagia">dysphagia</a> and chest pain. As Scleroderma progresses, esophageal involvement from abnormalities in decreased motility may worsen due to progressive fibrosis (scarring). If this is left untreated, acid from the stomach can back up into the esophagus causing <a href="/wiki/Esophagitis" title="Esophagitis">esophagitis</a>, and <a href="/wiki/Gastroesophageal_reflux_disease" title="Gastroesophageal reflux disease">GERD</a>. Further scarring from acid damage to the lower esophagus many times leads to the development of fibrotic narrowing, also known as strictures which can be treated by dilatation, and <a href="/wiki/Barrett%27s_esophagus" title="Barrett's esophagus">Barrett's esophagus</a>. The <a href="/wiki/Small_intestine" title="Small intestine">small intestine</a> can also become involved, leading to <a href="/wiki/Bacterial_overgrowth" title="Bacterial overgrowth" class="mw-redirect">bacterial overgrowth</a> and <a href="/wiki/Malabsorption" title="Malabsorption">malabsorption</a>, of <a href="/wiki/Bile_salts" title="Bile salts" class="mw-redirect">bile salts</a>, <a href="/wiki/Fat" title="Fat">fats</a>, <a href="/wiki/Carbohydrate" title="Carbohydrate">carbohydrates</a>, <a href="/wiki/Protein" title="Protein">proteins</a>, and <a href="/wiki/Vitamin" title="Vitamin">vitamins</a>. The <a href="/wiki/Colon_(anatomy)" title="Colon (anatomy)" class="mw-redirect">colon</a> can be involved, and can cause <a href="/wiki/Ogilvie%27s_syndrome" title="Ogilvie's syndrome" class="mw-redirect">pseudo-obstruction</a> or <a href="/wiki/Ischemic_colitis" title="Ischemic colitis">ischemic colitis</a>.<sup id="cite_ref-Primer_4-3" class="reference"><a href="#cite_note-Primer-4"><span>[</span>4<span>]</span></a></sup></p>
<p>Rarer complications include <a href="/wiki/Pneumatosis_cystoides_intestinalis" title="Pneumatosis cystoides intestinalis" class="mw-redirect">pneumatosis cystoides intestinalis</a>, or gas pockets in the bowel wall, <a href="/wiki/Diverticulosis" title="Diverticulosis">wide mouthed diverticula</a> in the colon and <a href="/wiki/Esophagus" title="Esophagus">esophagus</a>, and <a href="/wiki/Cirrhosis" title="Cirrhosis">liver fibrosis</a>. Patients with severe gastrointestinal involvement can become profoundly <a href="/wiki/Malnutrition" title="Malnutrition">malnourished</a>.<sup id="cite_ref-Rose_9-1" class="reference"><a href="#cite_note-Rose-9"><span>[</span>9<span>]</span></a></sup></p>
<p>Scleroderma may also be associated with <a href="/wiki/Gastric_antral_vascular_ectasia" title="Gastric antral vascular ectasia">gastric antral vascular ectasia</a> (GAVE), also known as <i>watermelon stomach</i>. This is a condition where atypical blood vessels proliferate usually in a radially symmetric pattern around the <a href="/wiki/Pylorus" title="Pylorus">pylorus</a> of the stomach. GAVE can be a cause of <a href="/wiki/Upper_gastrointestinal_bleeding" title="Upper gastrointestinal bleeding">upper gastrointestinal bleeding</a> or <a href="/wiki/Iron_deficiency_anemia" title="Iron deficiency anemia" class="mw-redirect">iron deficiency anemia</a> in patients with scleroderma.<sup id="cite_ref-Rose_9-2" class="reference"><a href="#cite_note-Rose-9"><span>[</span>9<span>]</span></a></sup></p>
<dl>
<dt>Kidneys</dt>
</dl>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Thrombotic_microangiopathy_-_very_high_mag.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/78/Thrombotic_microangiopathy_-_very_high_mag.jpg/220px-Thrombotic_microangiopathy_-_very_high_mag.jpg" width="220" height="147" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/78/Thrombotic_microangiopathy_-_very_high_mag.jpg/330px-Thrombotic_microangiopathy_-_very_high_mag.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/78/Thrombotic_microangiopathy_-_very_high_mag.jpg/440px-Thrombotic_microangiopathy_-_very_high_mag.jpg 2x" data-file-width="4272" data-file-height="2848" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Thrombotic_microangiopathy_-_very_high_mag.jpg" class="internal" title="Enlarge"></a></div>
<a href="/wiki/Micrograph" title="Micrograph">Micrograph</a> showing <a href="/wiki/Thrombotic_microangiopathy" title="Thrombotic microangiopathy">thrombotic microangiopathy</a>, the <a href="/wiki/Histomorphology" title="Histomorphology" class="mw-redirect">histomorphologic</a> finding seen in scleroderma renal crisis. <a href="/wiki/Kidney_biopsy" title="Kidney biopsy" class="mw-redirect">Kidney biopsy</a>. <a href="/wiki/PAS_stain" title="PAS stain" class="mw-redirect">PAS stain</a>.</div>
</div>
</div>
<p>Renal involvement, in scleroderma, is considered a poor prognostic factor and frequently a cause of death.<sup id="cite_ref-11" class="reference"><a href="#cite_note-11"><span>[</span>11<span>]</span></a></sup></p>
<p>The most important clinical complication of scleroderma involving the kidney is <i>scleroderma renal crisis</i>. Symptoms of scleroderma renal crisis are <a href="/wiki/Malignant_hypertension" title="Malignant hypertension" class="mw-redirect">malignant hypertension</a> (high blood pressure with evidence of acute organ damage), <a href="/wiki/Renin" title="Renin">hyperreninemia</a> (high renin levels), <a href="/wiki/Azotemia" title="Azotemia">azotemia</a> (kidney failure with accumulation of waste products in the blood) and <a href="/wiki/Microangiopathic_hemolytic_anemia" title="Microangiopathic hemolytic anemia">microangiopathic hemolytic anemia</a> (destruction of red blood cells).<sup id="cite_ref-12" class="reference"><a href="#cite_note-12"><span>[</span>12<span>]</span></a></sup> Apart from the high blood pressure, <a href="/wiki/Hematuria" title="Hematuria">hematuria</a> (blood in the urine) and <a href="/wiki/Proteinuria" title="Proteinuria">proteinuria</a> (protein loss in the urine) may be indicative.<sup id="cite_ref-13" class="reference"><a href="#cite_note-13"><span>[</span>13<span>]</span></a></sup></p>
<p>In the past scleroderma renal crisis was almost uniformily fatal.<sup id="cite_ref-steen_14-0" class="reference"><a href="#cite_note-steen-14"><span>[</span>14<span>]</span></a></sup> While outcomes have improved significantly with the use of <a href="/wiki/ACE_inhibitors" title="ACE inhibitors" class="mw-redirect">ACE inhibitors</a><sup id="cite_ref-15" class="reference"><a href="#cite_note-15"><span>[</span>15<span>]</span></a></sup><sup id="cite_ref-steen11033587_16-0" class="reference"><a href="#cite_note-steen11033587-16"><span>[</span>16<span>]</span></a></sup> the prognosis is often guarded, as a significant number of patients are refractory to treatment and develop <a href="/wiki/Renal_failure" title="Renal failure">renal failure</a>. Approximately 5-10% of all scleroderma patients develop renal crisis at some point in the course of their disease.<sup id="cite_ref-jimenez_17-0" class="reference"><a href="#cite_note-jimenez-17"><span>[</span>17<span>]</span></a></sup> Patients that have rapid skin involvement have the highest risk of renal complications.<sup id="cite_ref-jimenez_17-1" class="reference"><a href="#cite_note-jimenez-17"><span>[</span>17<span>]</span></a></sup> It is most common in diffuse cutaneous scleroderma, and is often associated with antibodies against <a href="/wiki/RNA_polymerase" title="RNA polymerase">RNA polymerase</a> (in 59% of cases). Many proceed to dialysis, although this can be stopped within three years in about a third of cases. Higher age and (paradoxically) a lower blood pressure at presentation make it more likely that dialysis is needed.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18"><span>[</span>18<span>]</span></a></sup></p>
<p>Treatments for scleroderma renal crisis include <a href="/wiki/ACE_inhibitors" title="ACE inhibitors" class="mw-redirect">ACE inhibitors</a>. Prophylactic use of ACE-inhibitors is currently not recommended, as recent data suggest a poorer prognosis in patient treated with these drugs prior to the development of renal crisis.<sup id="cite_ref-19" class="reference"><a href="#cite_note-19"><span>[</span>19<span>]</span></a></sup><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)"><span title="Material near this tag may use an unreliable or less reliable medical source. (November 2014)">unreliable medical source?</span></a></i>]</sup> Transplanted kidneys are known to be affected by scleroderma and patients with early onset renal disease (within one year of the scleroderma diagnosis) are thought to have the highest risk for recurrence.<sup id="cite_ref-20" class="reference"><a href="#cite_note-20"><span>[</span>20<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Systemic_scleroderma&amp;action=edit&amp;section=4" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Diagnosis is by clinical suspicion, presence of autoantibodies (specifically <a href="/wiki/Anti-centromere_antibodies" title="Anti-centromere antibodies">anti-centromere</a> and anti-scl70/<a href="/wiki/Anti-topoisomerase_antibodies" title="Anti-topoisomerase antibodies">anti-topoisomerase antibodies</a>) and occasionally by biopsy. Of the antibodies, 90% have a detectable <a href="/wiki/Anti-nuclear_antibody" title="Anti-nuclear antibody">anti-nuclear antibody</a>. Anti-centromere antibody is more common in the limited form (80-90%) than in the diffuse form (10%), and anti-scl70 is more common in the diffuse form (30-40%) and in <a href="/wiki/African-American" title="African-American" class="mw-redirect">African-American</a> patients (who are more susceptible to the systemic form).<sup id="cite_ref-JimenezDerk_21-0" class="reference"><a href="#cite_note-JimenezDerk-21"><span>[</span>21<span>]</span></a></sup></p>
<p>In 1980 the <a href="/wiki/American_College_of_Rheumatology" title="American College of Rheumatology">American College of Rheumatology</a> agreed upon diagnostic criteria for scleroderma.<sup id="cite_ref-22" class="reference"><a href="#cite_note-22"><span>[</span>22<span>]</span></a></sup></p>
<p>Other conditions may mimic systemic sclerosis by causing hardening of the skin. Diagnostic hints that another disorder is responsible include the absence of <a href="/wiki/Raynaud%27s_phenomenon" title="Raynaud's phenomenon">Raynaud's phenomenon</a>, a lack of abnormalities in the skin on the hands, a lack of internal organ involvement, and a normal antinuclear antibodies test result.<sup id="cite_ref-23" class="reference"><a href="#cite_note-23"><span>[</span>23<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Causes">Causes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Systemic_scleroderma&amp;action=edit&amp;section=5" title="Edit section: Causes">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>There is no clear obvious cause for scleroderma and systemic sclerosis. Genetic predisposition appears to be limited: genetic concordance is small; still, there often is a familial predisposition for autoimmune disease. Polymorphisms in <i><a href="/wiki/COL1A2" title="COL1A2">COL1A2</a></i> and <i><a href="/wiki/TGF_beta_1" title="TGF beta 1">TGF-β1</a></i> may influence severity and development of the disease. There is limited evidence implicating <a href="/wiki/Cytomegalovirus" title="Cytomegalovirus">cytomegalovirus</a> (CMV) as the original epitope of the immune reaction, as well as parvovirus B19.<sup id="cite_ref-24" class="reference"><a href="#cite_note-24"><span>[</span>24<span>]</span></a></sup> <a href="/wiki/Organic_solvent" title="Organic solvent" class="mw-redirect">Organic solvents</a> and other chemical agents have been linked with scleroderma.<sup id="cite_ref-JimenezDerk_21-1" class="reference"><a href="#cite_note-JimenezDerk-21"><span>[</span>21<span>]</span></a></sup></p>
<p>One of the suspected mechanisms behind the autoimmune phenomenon is the existence of <a href="/wiki/Microchimerism" title="Microchimerism">microchimerism</a>, i.e. fetal cells circulating in maternal blood, triggering an immune reaction to what is perceived as "foreign" material.<sup id="cite_ref-Bianchi_25-0" class="reference"><a href="#cite_note-Bianchi-25"><span>[</span>25<span>]</span></a></sup><sup id="cite_ref-JimenezDerk_21-2" class="reference"><a href="#cite_note-JimenezDerk-21"><span>[</span>21<span>]</span></a></sup></p>
<p>A distinct form of scleroderma and systemic sclerosis may develop in patients with <a href="/wiki/Chronic_renal_failure" title="Chronic renal failure" class="mw-redirect">chronic renal failure</a>. This entity, <a href="/wiki/Nephrogenic_fibrosing_dermopathy" title="Nephrogenic fibrosing dermopathy" class="mw-redirect">nephrogenic fibrosing dermopathy</a> or nephrogenic systemic fibrosis,<sup id="cite_ref-pmid20299369_26-0" class="reference"><a href="#cite_note-pmid20299369-26"><span>[</span>26<span>]</span></a></sup><sup id="cite_ref-pmid20120045_27-0" class="reference"><a href="#cite_note-pmid20120045-27"><span>[</span>27<span>]</span></a></sup><sup id="cite_ref-pmid20118047_28-0" class="reference"><a href="#cite_note-pmid20118047-28"><span>[</span>28<span>]</span></a></sup><sup id="cite_ref-pmid20063400_29-0" class="reference"><a href="#cite_note-pmid20063400-29"><span>[</span>29<span>]</span></a></sup> has been linked to the exposure to <a href="/wiki/Gadolinium" title="Gadolinium">gadolinium</a>-containing <a href="/wiki/Radiocontrast" title="Radiocontrast" class="mw-redirect">radiocontrast</a>.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30"><span>[</span>30<span>]</span></a></sup></p>
<p><a href="/wiki/Bleomycin" title="Bleomycin">Bleomycin</a><sup id="cite_ref-31" class="reference"><a href="#cite_note-31"><span>[</span>31<span>]</span></a></sup> (a chemotherapeutic agent) and possibly <a href="/wiki/Taxane" title="Taxane">taxane</a> chemotherapy<sup id="cite_ref-32" class="reference"><a href="#cite_note-32"><span>[</span>32<span>]</span></a></sup> may cause scleroderma, and occupational exposure to <a href="/wiki/Solvent" title="Solvent">solvents</a> has been linked with an increased risk of systemic sclerosis.<sup id="cite_ref-33" class="reference"><a href="#cite_note-33"><span>[</span>33<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Pathophysiology">Pathophysiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Systemic_scleroderma&amp;action=edit&amp;section=6" title="Edit section: Pathophysiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The overproduction of collagen is thought to result from an <a href="/wiki/Autoimmune_disorder" title="Autoimmune disorder" class="mw-redirect">autoimmune dysfunction</a>, in which the immune system would start to attack the <a href="/wiki/Kinetochore" title="Kinetochore">kinetochore</a> of the chromosomes. This would lead to genetic malfunction of nearby genes. <a href="/wiki/T_cell" title="T cell">T cells</a> accumulate in the skin; these are thought to secrete <a href="/wiki/Cytokine" title="Cytokine">cytokines</a> and other proteins that stimulate collagen deposition. Stimulation of the <a href="/wiki/Fibroblast" title="Fibroblast">fibroblast</a>, in particular, seems to be crucial to the disease process, and studies have converged on the potential factors that produce this effect.<sup id="cite_ref-JimenezDerk_21-3" class="reference"><a href="#cite_note-JimenezDerk-21"><span>[</span>21<span>]</span></a></sup></p>
<p>A significant player in the process is <a href="/wiki/Transforming_growth_factor" title="Transforming growth factor">transforming growth factor</a> (TGFβ). This protein appears to be overproduced, and the fibroblast (possibly in response to other stimuli) also overexpresses the receptor for this mediator. An intracellular pathway (consisting of <i><a href="/wiki/SMAD2" title="SMAD2" class="mw-redirect">SMAD2</a>/<a href="/wiki/SMAD3" title="SMAD3" class="mw-redirect">SMAD3</a></i>, <i><a href="/wiki/SMAD4" title="SMAD4" class="mw-redirect">SMAD4</a></i> and the inhibitor <i><a href="/wiki/SMAD7" title="SMAD7" class="mw-redirect">SMAD7</a></i>) is responsible for the secondary messenger system that induces <a href="/wiki/Transcription_(genetics)" title="Transcription (genetics)">transcription</a> of the proteins and enzymes responsible for collagen deposition. <i>Sp1</i> is a <a href="/wiki/Transcription_factor" title="Transcription factor">transcription factor</a> most closely studied in this context. Apart from TGFβ, <a href="/wiki/Connective_tissue_growth_factor" title="Connective tissue growth factor" class="mw-redirect">connective tissue growth factor</a> (CTGF) has a possible role.<sup id="cite_ref-JimenezDerk_21-4" class="reference"><a href="#cite_note-JimenezDerk-21"><span>[</span>21<span>]</span></a></sup> Indeed, a common <i>CTGF</i> gene polymorphism is present at an increased rate in systemic sclerosis.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34"><span>[</span>34<span>]</span></a></sup></p>
<p>Damage to <a href="/wiki/Endothelium" title="Endothelium">endothelium</a> is an early abnormality in the development of scleroderma, and this too seems to be due to collagen accumulation by fibroblasts, although direct alterations by cytokines, <a href="/wiki/Platelet" title="Platelet">platelet</a> adhesion and a type II hypersensitivity reaction have similarly been implicated. Increased <a href="/wiki/Endothelin" title="Endothelin">endothelin</a> and decreased <a href="/wiki/Vasodilation" title="Vasodilation">vasodilation</a> has been documented.<sup id="cite_ref-JimenezDerk_21-5" class="reference"><a href="#cite_note-JimenezDerk-21"><span>[</span>21<span>]</span></a></sup></p>
<p>Jimenez &amp; Derk<sup id="cite_ref-JimenezDerk_21-6" class="reference"><a href="#cite_note-JimenezDerk-21"><span>[</span>21<span>]</span></a></sup> describe three theories about the development of scleroderma:</p>
<ul>
<li>The abnormalities are primarily due to a physical agent, and all other changes are secondary or reactive to this direct insult.</li>
<li>The initial event is fetomaternal cell transfer causing microchimerism, with a second summative cause (e.g. environmental) leading to the actual development of the disease.</li>
<li>Physical causes lead to phenotypic alterations in susceptible cells (e.g. due to genetic makeup), which then effectuate DNA changes which alter the cell's behavior.</li>
</ul>
<h2><span class="mw-headline" id="Therapy">Therapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Systemic_scleroderma&amp;action=edit&amp;section=7" title="Edit section: Therapy">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>There is no cure for scleroderma, though there is treatment for some of the symptoms, including drugs that soften the skin and reduce inflammation. Some patients may benefit from exposure to heat.<sup id="cite_ref-35" class="reference"><a href="#cite_note-35"><span>[</span>35<span>]</span></a></sup> Holistic care of patient comprising patient education tailored to patient's education level is useful in view of the complex nature of the disease symptoms and progress.<sup id="cite_ref-36" class="reference"><a href="#cite_note-36"><span>[</span>36<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Topical.2Fsymptomatic">Topical/symptomatic</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Systemic_scleroderma&amp;action=edit&amp;section=8" title="Edit section: Topical/symptomatic">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Topical treatment for the skin changes of scleroderma do not alter the disease course, but may improve pain and ulceration. A range of <a href="/wiki/NSAID" title="NSAID" class="mw-redirect">NSAIDs</a> (nonsteroidal anti-inflammatory drugs) can be used to ease painful symptoms, such as <a href="/wiki/Naproxen" title="Naproxen">naproxen</a>.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (May 2008)">citation needed</span></a></i>]</sup> There is limited benefit from <a href="/wiki/Glucocorticoid" title="Glucocorticoid">steroids</a> such as prednisone.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (May 2008)">citation needed</span></a></i>]</sup> Episodes of Raynaud's phenomenon sometimes respond to <a href="/wiki/Nifedipine" title="Nifedipine">nifedipine</a> or other calcium channel blockers; severe digital ulceration may respond to <a href="/wiki/Prostacyclin" title="Prostacyclin">prostacyclin</a> analogue <a href="/wiki/Iloprost" title="Iloprost">iloprost</a>, and the dual endothelin-receptor antagonist <a href="/wiki/Bosentan" title="Bosentan">bosentan</a> may be beneficial for Raynaud's phenomenon.<sup id="cite_ref-Zandberg_37-0" class="reference"><a href="#cite_note-Zandberg-37"><span>[</span>37<span>]</span></a></sup> The skin tightness may be treated systemically with <a href="/wiki/Methotrexate" title="Methotrexate">methotrexate</a> and <a href="/wiki/Ciclosporin" title="Ciclosporin">ciclosporin</a>.<sup id="cite_ref-Zandberg_37-1" class="reference"><a href="#cite_note-Zandberg-37"><span>[</span>37<span>]</span></a></sup> and the skin thickness treated with penicillamine.</p>
<h3><span class="mw-headline" id="Kidney_disease">Kidney disease</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Systemic_scleroderma&amp;action=edit&amp;section=9" title="Edit section: Kidney disease">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Scleroderma renal crisis, the occurrence of <a href="/wiki/Acute_renal_failure" title="Acute renal failure" class="mw-redirect">acute renal failure</a> and <a href="/wiki/Malignant_hypertension" title="Malignant hypertension" class="mw-redirect">malignant hypertension</a> (very high blood pressure with evidence of organ damage) in people with scleroderma, is effectively treated with drugs from the class of the <a href="/wiki/ACE_inhibitor" title="ACE inhibitor">ACE inhibitors</a>. The benefit of ACE inhibitors extends even to those who have to commence <a href="/wiki/Hemodialysis" title="Hemodialysis">dialysis</a> to treat their kidney disease, and may give sufficient benefit to allow the discontinuation of renal replacement therapy.<sup id="cite_ref-Zandberg_37-2" class="reference"><a href="#cite_note-Zandberg-37"><span>[</span>37<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Lung_disease_and_pulmonary_hypertension">Lung disease and pulmonary hypertension</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Systemic_scleroderma&amp;action=edit&amp;section=10" title="Edit section: Lung disease and pulmonary hypertension">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Active alveolitis is often treated with pulses of <a href="/wiki/Cyclophosphamide" title="Cyclophosphamide">cyclophosphamide</a>, often together with a small dose of steroids. The benefit of this intervention is modest.<sup id="cite_ref-38" class="reference"><a href="#cite_note-38"><span>[</span>38<span>]</span></a></sup><sup id="cite_ref-39" class="reference"><a href="#cite_note-39"><span>[</span>39<span>]</span></a></sup></p>
<p>Pulmonary hypertension may be treated with <a href="/wiki/Epoprostenol" title="Epoprostenol" class="mw-redirect">epoprostenol</a>, <a href="/wiki/Bosentan" title="Bosentan">bosentan</a> and possibly aerolized iloprost.<sup id="cite_ref-Zandberg_37-3" class="reference"><a href="#cite_note-Zandberg-37"><span>[</span>37<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Experimental_treatments">Experimental treatments</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Systemic_scleroderma&amp;action=edit&amp;section=11" title="Edit section: Experimental treatments">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Given the difficulty in treating scleroderma, treatments with a smaller <a href="/wiki/Evidence_based_medicine" title="Evidence based medicine" class="mw-redirect">evidence base</a> are often tried to control the disease. These include <a href="/wiki/Antithymocyte_globulin" title="Antithymocyte globulin" class="mw-redirect">antithymocyte globulin</a> and <a href="/wiki/Mycophenolate_mofetil" title="Mycophenolate mofetil" class="mw-redirect">mycophenolate mofetil</a>; some reports have reported improvements in the skin symptoms as well as delaying the progress of systemic disease, but neither of them have been subjected to large clinical trials.<sup id="cite_ref-Zandberg_37-4" class="reference"><a href="#cite_note-Zandberg-37"><span>[</span>37<span>]</span></a></sup></p>
<p>Autologous <a href="/wiki/Hematopoietic_stem_cell_transplantation" title="Hematopoietic stem cell transplantation">hematopoietic stem cell transplantation</a> (HSCT) is based on the assumption that autoimmune diseases like systemic sclerosis occur when the white blood cells of the immune system attack the body. In this treatment, stem cells from the patient's blood are extracted and stored to preserve them. The patient's white blood cells are destroyed with cyclophosphamide and rabbit antibodies against the white blood cells. Then the stored blood is returned to the patient's bloodstream to reconstitute a healthy blood and immune system which will not attack the body. The results of a phase 3 trial, the Autologous Stem Cell Trnsplantation International Scleroderma (ASTIS) trial, with 156 patients were published in 2014. HSCT itself has a high treatment mortality, so in the first year, the survival of patients in the treatment group was lower than the placebo group, but at the end of 10 years, the survival in the treatment group was significantly higher. The authors concluded that HSCT could be effective, if limited to patients who were healthy enough to survive HSCT itself. Therefore, HSCT should be given early in the progression of the disease, before it does damage. Patients with heart disease, and patients who smoked cigarettes, were less likely to survive.<sup id="cite_ref-JAMA2014-editorial_40-0" class="reference"><a href="#cite_note-JAMA2014-editorial-40"><span>[</span>40<span>]</span></a></sup><sup id="cite_ref-JAMA2014_41-0" class="reference"><a href="#cite_note-JAMA2014-41"><span>[</span>41<span>]</span></a></sup> Another trial, the Stem Cell Transplant vs. Cyclophosphamide (SCOT) trial, is ongoing.<sup id="cite_ref-42" class="reference"><a href="#cite_note-42"><span>[</span>42<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Systemic_scleroderma&amp;action=edit&amp;section=12" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<table class="metadata plainlinks ambox ambox-content ambox-globalize" role="presentation">
<tr>
<td class="mbox-image">
<div style="width:52px"><img alt="Globe icon." src="//upload.wikimedia.org/wikipedia/commons/thumb/b/bd/Ambox_globe_content.svg/48px-Ambox_globe_content.svg.png" width="48" height="40" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/bd/Ambox_globe_content.svg/73px-Ambox_globe_content.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/bd/Ambox_globe_content.svg/97px-Ambox_globe_content.svg.png 2x" data-file-width="350" data-file-height="290" /></div>
</td>
<td class="mbox-text"><span class="mbox-text-span">The examples and perspective in this article <b>may not represent a <a href="/wiki/Wikipedia:WikiProject_Countering_systemic_bias" title="Wikipedia:WikiProject Countering systemic bias">worldwide view</a> of the subject</b>. <span class="hide-when-compact">Please <a class="external text" href="//en.wikipedia.org/w/index.php?title=Systemic_scleroderma&amp;action=edit">improve this article</a> and discuss the issue on the <a href="/wiki/Talk:Systemic_scleroderma" title="Talk:Systemic scleroderma">talk page</a>.</span> <small><i>(May 2008)</i></small></span></td>
</tr>
</table>
<p>Systemic scleroderma is a <a href="/wiki/Rare_disease" title="Rare disease">rare disease</a><sup id="cite_ref-43" class="reference"><a href="#cite_note-43"><span>[</span>43<span>]</span></a></sup> with an annual incidence of 1 to 2 per 100,000 individuals in the United States. The interval of peak onset starts at age 30<sup id="cite_ref-uptodate_44-0" class="reference"><a href="#cite_note-uptodate-44"><span>[</span>44<span>]</span></a></sup> to 35<sup id="cite_ref-umm_45-0" class="reference"><a href="#cite_note-umm-45"><span>[</span>45<span>]</span></a></sup> and ends at age 50<sup id="cite_ref-uptodate_44-1" class="reference"><a href="#cite_note-uptodate-44"><span>[</span>44<span>]</span></a></sup> to 55.<sup id="cite_ref-umm_45-1" class="reference"><a href="#cite_note-umm-45"><span>[</span>45<span>]</span></a></sup></p>
<p>In the United States, the prevalence of systemic scleroderma is about 50,000,<sup id="cite_ref-umm_45-2" class="reference"><a href="#cite_note-umm-45"><span>[</span>45<span>]</span></a></sup> with different studies giving different estimates, usually ranging between 40,000 and 165,000.<sup id="cite_ref-46" class="reference"><a href="#cite_note-46"><span>[</span>46<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Advocacy">Advocacy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Systemic_scleroderma&amp;action=edit&amp;section=13" title="Edit section: Advocacy">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The Juvenile Scleroderma Network is an organization dedicated to provide emotional support and educational information to parents and their children living with juvenile scleroderma, to support pediatric research to identify the cause of and the cure for juvenile scleroderma, and to enhance public awareness.<sup id="cite_ref-47" class="reference"><a href="#cite_note-47"><span>[</span>47<span>]</span></a></sup></p>
<p>In the US, the <a href="/wiki/Scleroderma_Research_Foundation" title="Scleroderma Research Foundation">Scleroderma Research Foundation</a> is dedicated to raise awareness of the disease and assist those who are affected.<sup id="cite_ref-48" class="reference"><a href="#cite_note-48"><span>[</span>48<span>]</span></a></sup> The Scleroderma Research Foundation sponsors research into the condition.<sup id="cite_ref-49" class="reference"><a href="#cite_note-49"><span>[</span>49<span>]</span></a></sup> Comedian and television presenter <a href="/wiki/Bob_Saget" title="Bob Saget">Bob Saget</a>, a board member of the SRF, directed the 1996 ABC TV movie <a href="/wiki/For_Hope" title="For Hope">For Hope</a>, starring <a href="/wiki/Dana_Delany" title="Dana Delany">Dana Delany</a>, which depicts a young woman fatally affected by scleroderma; the film was based on the experiences of Saget's sister Gay.<sup id="cite_ref-50" class="reference"><a href="#cite_note-50"><span>[</span>50<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Systemic_scleroderma&amp;action=edit&amp;section=14" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-count references-column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-Harrison.27s-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-Harrison.27s_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Harrison.27s_1-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Longo, Dan L.; Kasper, Dennis L; Fauci, Anthony; Hauser, Stephen L.; et al., ed. (July 2011) [2005]. <i>Harrison's Principles of Internal Medicine</i> (16th ed.). New York: McGraw-Hill. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/007174889X" title="Special:BookSources/007174889X">007174889X</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.btitle=Harrison%27s+Principles+of+Internal+Medicine&amp;rft.date=July+2011&amp;rft.edition=16th&amp;rft.genre=book&amp;rft.isbn=007174889X&amp;rft.place=New+York&amp;rft.pub=McGraw-Hill&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-2">^</a></b></span> <span class="reference-text"><span class="citation journal">Onishi A, Sugiyama D, Kumagai S, Morinobu A (July 2013). "Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies". <i>Arthritis Rheum.</i> <b>65</b> (7): 1913–21. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fart.37969">10.1002/art.37969</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23576072">23576072</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Cancer+incidence+in+systemic+sclerosis%3A+meta-analysis+of+population-based+cohort+studies&amp;rft.aulast=Onishi+A%2C+Sugiyama+D%2C+Kumagai+S%2C+Morinobu+A&amp;rft.au=Onishi+A%2C+Sugiyama+D%2C+Kumagai+S%2C+Morinobu+A&amp;rft.date=July+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fart.37969&amp;rft_id=info%3Apmid%2F23576072&amp;rft.issue=7&amp;rft.jtitle=Arthritis+Rheum.&amp;rft.pages=1913-21&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=65" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-3">^</a></b></span> <span class="reference-text"><span class="citation journal">Hinchcliff M, Varga J (October 2008). "Systemic sclerosis/scleroderma: a treatable multisystem disease". <i>Am Fam Physician</i> <b>78</b> (8): 961–8. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18953973">18953973</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Systemic+sclerosis%2Fscleroderma%3A+a+treatable+multisystem+disease&amp;rft.au=Hinchcliff+M%2C+Varga+J&amp;rft.aulast=Hinchcliff+M%2C+Varga+J&amp;rft.date=October+2008&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F18953973&amp;rft.issue=8&amp;rft.jtitle=Am+Fam+Physician&amp;rft.pages=961-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=78" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Primer-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-Primer_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Primer_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Primer_4-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Primer_4-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Klippel, John H. <i>Primer On the Rheumatic Diseases 11ED</i>. Atlanta, GA: Arthritis Foundation. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/1-912423-16-2" title="Special:BookSources/1-912423-16-2">1-912423-16-2</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.au=Klippel%2C+John+H.&amp;rft.aulast=Klippel%2C+John+H.&amp;rft.btitle=Primer+On+the+Rheumatic+Diseases+11ED&amp;rft.genre=book&amp;rft.isbn=1-912423-16-2&amp;rft.place=Atlanta%2C+GA&amp;rft.pub=Arthritis+Foundation&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><span class="citation journal">Valentini G, Black C (2002). "Systemic sclerosis". <i>Best practice &amp; research. Clinical rheumatology</i> <b>16</b> (5): 807–16. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1053%2Fberh.2002.0258">10.1053/berh.2002.0258</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12473275">12473275</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Systemic+sclerosis&amp;rft.aulast=Valentini+G%2C+Black+C&amp;rft.au=Valentini+G%2C+Black+C&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1053%2Fberh.2002.0258&amp;rft_id=info%3Apmid%2F12473275&amp;rft.issue=5&amp;rft.jtitle=Best+practice+%26+research.+Clinical+rheumatology&amp;rft.pages=807-16&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=16" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><span class="citation journal">Olsen NJ, King LE, Park JH (1996). "Muscle abnormalities in scleroderma". <i>Rheum. Dis. Clin. North Am.</i> <b>22</b> (4): 783–96. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0889-857X%2805%2970301-X">10.1016/S0889-857X(05)70301-X</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8923596">8923596</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Muscle+abnormalities+in+scleroderma&amp;rft.aulast=Olsen+NJ%2C+King+LE%2C+Park+JH&amp;rft.au=Olsen+NJ%2C+King+LE%2C+Park+JH&amp;rft.date=1996&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0889-857X%2805%2970301-X&amp;rft_id=info%3Apmid%2F8923596&amp;rft.issue=4&amp;rft.jtitle=Rheum.+Dis.+Clin.+North+Am.&amp;rft.pages=783-96&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=22" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><span class="citation journal">Steen VD (2005). "The lung in systemic sclerosis". <i>Journal of clinical rheumatology</i> <b>11</b> (1): 40–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F01.rhu.0000152147.38706.db">10.1097/01.rhu.0000152147.38706.db</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16357695">16357695</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=The+lung+in+systemic+sclerosis&amp;rft.aulast=Steen+VD&amp;rft.au=Steen+VD&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F01.rhu.0000152147.38706.db&amp;rft_id=info%3Apmid%2F16357695&amp;rft.issue=1&amp;rft.jtitle=Journal+of+clinical+rheumatology&amp;rft.pages=40-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=11" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Sallam-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-Sallam_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Sallam_8-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Sallam_8-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Sallam H, McNearney TA, Chen JD (2006). "Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma)". <i>Aliment. Pharmacol. Ther.</i> <b>23</b> (6): 691–712. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1365-2036.2006.02804.x">10.1111/j.1365-2036.2006.02804.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16556171">16556171</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Systematic+review%3A+pathophysiology+and+management+of+gastrointestinal+dysmotility+in+systemic+sclerosis+%28scleroderma%29&amp;rft.aulast=Sallam+H%2C+McNearney+TA%2C+Chen+JD&amp;rft.au=Sallam+H%2C+McNearney+TA%2C+Chen+JD&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2036.2006.02804.x&amp;rft_id=info%3Apmid%2F16556171&amp;rft.issue=6&amp;rft.jtitle=Aliment.+Pharmacol.+Ther.&amp;rft.pages=691-712&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Rose-9"><span class="mw-cite-backlink">^ <a href="#cite_ref-Rose_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Rose_9-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Rose_9-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Rose S, Young MA, Reynolds JC (1998). "Gastrointestinal manifestations of scleroderma". <i>Gastroenterol. Clin. North Am.</i> <b>27</b> (3): 563–94. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0889-8553%2805%2970021-2">10.1016/S0889-8553(05)70021-2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9891698">9891698</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Gastrointestinal+manifestations+of+scleroderma&amp;rft.aulast=Rose+S%2C+Young+MA%2C+Reynolds+JC&amp;rft.au=Rose+S%2C+Young+MA%2C+Reynolds+JC&amp;rft.date=1998&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0889-8553%2805%2970021-2&amp;rft_id=info%3Apmid%2F9891698&amp;rft.issue=3&amp;rft.jtitle=Gastroenterol.+Clin.+North+Am.&amp;rft.pages=563-94&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=27" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><span class="citation journal">Hendel L, Hage E, Hendel J, Stentoft P (1992). "Omeprazole in the long-term treatment of severe gastro-oesophageal reflux disease in patients with systemic sclerosis". <i>Aliment. Pharmacol. Ther.</i> <b>6</b> (5): 565–77. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1365-2036.1992.tb00571.x">10.1111/j.1365-2036.1992.tb00571.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1420748">1420748</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Omeprazole+in+the+long-term+treatment+of+severe+gastro-oesophageal+reflux+disease+in+patients+with+systemic+sclerosis&amp;rft.au=Hendel+L%2C+Hage+E%2C+Hendel+J%2C+Stentoft+P&amp;rft.aulast=Hendel+L%2C+Hage+E%2C+Hendel+J%2C+Stentoft+P&amp;rft.date=1992&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2036.1992.tb00571.x&amp;rft_id=info%3Apmid%2F1420748&amp;rft.issue=5&amp;rft.jtitle=Aliment.+Pharmacol.+Ther.&amp;rft.pages=565-77&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=6" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text"><span class="citation journal">Ruangjutipopan S, Kasitanon N, Louthrenoo W, Sukitawut W, Wichainun R (2002). "Causes of death and poor survival prognostic factors in thai patients with systemic sclerosis". <i>Journal of the Medical Association of Thailand</i> <b>85</b> (11): 1204–9. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12546318">12546318</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Causes+of+death+and+poor+survival+prognostic+factors+in+thai+patients+with+systemic+sclerosis&amp;rft.aulast=Ruangjutipopan+S%2C+Kasitanon+N%2C+Louthrenoo+W%2C+Sukitawut+W%2C+Wichainun+R&amp;rft.au=Ruangjutipopan+S%2C+Kasitanon+N%2C+Louthrenoo+W%2C+Sukitawut+W%2C+Wichainun+R&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F12546318&amp;rft.issue=11&amp;rft.jtitle=Journal+of+the+Medical+Association+of+Thailand&amp;rft.pages=1204-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=85" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><span class="citation journal">Steen VD, Mayes MD, Merkel PA (2003). "Assessment of kidney involvement". <i>Clin. Exp. Rheumatol.</i> <b>21</b> (3 Suppl 29): S29–31. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12889219">12889219</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Assessment+of+kidney+involvement&amp;rft.aulast=Steen+VD%2C+Mayes+MD%2C+Merkel+PA&amp;rft.au=Steen+VD%2C+Mayes+MD%2C+Merkel+PA&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F12889219&amp;rft.issue=3+Suppl+29&amp;rft.jtitle=Clin.+Exp.+Rheumatol.&amp;rft.pages=S29-31&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=21" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><span class="citation journal">Steen VD (1994). "Renal involvement in systemic sclerosis". <i>Clin. Dermatol.</i> <b>12</b> (2): 253–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0738-081X%2894%2990329-8">10.1016/S0738-081X(94)90329-8</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8076263">8076263</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Renal+involvement+in+systemic+sclerosis&amp;rft.aulast=Steen+VD&amp;rft.au=Steen+VD&amp;rft.date=1994&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0738-081X%2894%2990329-8&amp;rft_id=info%3Apmid%2F8076263&amp;rft.issue=2&amp;rft.jtitle=Clin.+Dermatol.&amp;rft.pages=253-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=12" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-steen-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-steen_14-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Steen VD (2003). "Scleroderma renal crisis". <i>Rheum. Dis. Clin. North Am.</i> <b>29</b> (2): 315–33. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0889-857X%2803%2900016-4">10.1016/S0889-857X(03)00016-4</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12841297">12841297</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Scleroderma+renal+crisis&amp;rft.aulast=Steen+VD&amp;rft.au=Steen+VD&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0889-857X%2803%2900016-4&amp;rft_id=info%3Apmid%2F12841297&amp;rft.issue=2&amp;rft.jtitle=Rheum.+Dis.+Clin.+North+Am.&amp;rft.pages=315-33&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=29" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><span class="citation journal">Rhew EY, Barr WG (2004). "Scleroderma renal crisis: new insights and developments". <i>Current rheumatology reports</i> <b>6</b> (2): 129–36. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs11926-004-0057-5">10.1007/s11926-004-0057-5</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15016343">15016343</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Scleroderma+renal+crisis%3A+new+insights+and+developments&amp;rft.aulast=Rhew+EY%2C+Barr+WG&amp;rft.au=Rhew+EY%2C+Barr+WG&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs11926-004-0057-5&amp;rft_id=info%3Apmid%2F15016343&amp;rft.issue=2&amp;rft.jtitle=Current+rheumatology+reports&amp;rft.pages=129-36&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=6" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-steen11033587-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-steen11033587_16-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Steen VD, Medsger TA (2000). "Long-term outcomes of scleroderma renal crisis". <i>Ann. Intern. Med.</i> <b>133</b> (8): 600–3. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.7326%2F0003-4819-133-8-200010170-00010">10.7326/0003-4819-133-8-200010170-00010</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11033587">11033587</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Long-term+outcomes+of+scleroderma+renal+crisis&amp;rft.aulast=Steen+VD%2C+Medsger+TA&amp;rft.au=Steen+VD%2C+Medsger+TA&amp;rft.date=2000&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-133-8-200010170-00010&amp;rft_id=info%3Apmid%2F11033587&amp;rft.issue=8&amp;rft.jtitle=Ann.+Intern.+Med.&amp;rft.pages=600-3&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=133" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-jimenez-17"><span class="mw-cite-backlink">^ <a href="#cite_ref-jimenez_17-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-jimenez_17-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Jimenez S, Koenig AS. <a rel="nofollow" class="external text" href="http://www.emedicine.com/MED/topic2076.htm">Scleroderma</a>. eMedicine.com. Accessed: May 22, 2006.</span></li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><span class="citation journal">Penn H, Howie AJ, Kingdon EJ et al. (August 2007). <a rel="nofollow" class="external text" href="http://qjmed.oxfordjournals.org/cgi/content/full/100/8/485">"Scleroderma renal crisis: patient characteristics and long-term outcomes"</a>. <i>QJM</i> <b>100</b> (8): 485–94. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fqjmed%2Fhcm052">10.1093/qjmed/hcm052</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17601770">17601770</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Scleroderma+renal+crisis%3A+patient+characteristics+and+long-term+outcomes&amp;rft.aulast=Penn+H%2C+Howie+AJ%2C+Kingdon+EJ&amp;rft.au=Penn+H%2C+Howie+AJ%2C+Kingdon+EJ&amp;rft.date=August+2007&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fqjmed.oxfordjournals.org%2Fcgi%2Fcontent%2Ffull%2F100%2F8%2F485&amp;rft_id=info%3Adoi%2F10.1093%2Fqjmed%2Fhcm052&amp;rft_id=info%3Apmid%2F17601770&amp;rft.issue=8&amp;rft.jtitle=QJM&amp;rft.pages=485-94&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=100" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><span class="citation journal">Hudson, M; Baron, M; Tatibouet, S; Furst, DE; Khanna, D; International Scleroderma Renal Crisis Study, Investigators (April 2014). "Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the International Scleroderma Renal Crisis Survey.". <i>Seminars in arthritis and rheumatism</i> <b>43</b> (5): 666–72. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.semarthrit.2013.09.008">10.1016/j.semarthrit.2013.09.008</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24176729">24176729</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Exposure+to+ACE+inhibitors+prior+to+the+onset+of+scleroderma+renal+crisis-results+from+the+International+Scleroderma+Renal+Crisis+Survey.&amp;rft.au=Baron%2C+M&amp;rft.aufirst=M&amp;rft.au=Furst%2C+DE&amp;rft.au=Hudson%2C+M&amp;rft.au=International+Scleroderma+Renal+Crisis+Study%2C+Investigators&amp;rft.au=Khanna%2C+D&amp;rft.aulast=Hudson&amp;rft.au=Tatibouet%2C+S&amp;rft.date=April+2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.semarthrit.2013.09.008&amp;rft_id=info%3Apmid%2F24176729&amp;rft.issue=5&amp;rft.jtitle=Seminars+in+arthritis+and+rheumatism&amp;rft.pages=666-72&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=43" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><span class="citation journal">Pham PT, Pham PC, Danovitch GM et al. (October 2005). <a rel="nofollow" class="external text" href="http://www.blackwell-synergy.com/doi/full/10.1111/j.1600-6143.2005.01035.x">"Predictors and risk factors for recurrent scleroderma renal crisis in the kidney allograft: case report and review of the literature"</a>. <i>Am. J. Transplant.</i> <b>5</b> (10): 2565–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1600-6143.2005.01035.x">10.1111/j.1600-6143.2005.01035.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16162209">16162209</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Predictors+and+risk+factors+for+recurrent+scleroderma+renal+crisis+in+the+kidney+allograft%3A+case+report+and+review+of+the+literature&amp;rft.aulast=Pham+PT%2C+Pham+PC%2C+Danovitch+GM&amp;rft.au=Pham+PT%2C+Pham+PC%2C+Danovitch+GM&amp;rft.date=October+2005&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.blackwell-synergy.com%2Fdoi%2Ffull%2F10.1111%2Fj.1600-6143.2005.01035.x&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1600-6143.2005.01035.x&amp;rft_id=info%3Apmid%2F16162209&amp;rft.issue=10&amp;rft.jtitle=Am.+J.+Transplant.&amp;rft.pages=2565-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-JimenezDerk-21"><span class="mw-cite-backlink">^ <a href="#cite_ref-JimenezDerk_21-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-JimenezDerk_21-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-JimenezDerk_21-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-JimenezDerk_21-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-JimenezDerk_21-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-JimenezDerk_21-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-JimenezDerk_21-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Jimenez SA, Derk CT (2004). "Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis". <i>Ann. Intern. Med.</i> <b>140</b> (1): 37–50. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.7326%2F0003-4819-140-2-200401200-00013">10.7326/0003-4819-140-2-200401200-00013</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14706971">14706971</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Following+the+molecular+pathways+toward+an+understanding+of+the+pathogenesis+of+systemic+sclerosis&amp;rft.au=Jimenez+SA%2C+Derk+CT&amp;rft.aulast=Jimenez+SA%2C+Derk+CT&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-140-2-200401200-00013&amp;rft_id=info%3Apmid%2F14706971&amp;rft.issue=1&amp;rft.jtitle=Ann.+Intern.+Med.&amp;rft.pages=37-50&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=140" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><span class="citation journal">"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee". <i>Arthritis Rheum.</i> <b>23</b> (5): 581–90. 1980. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fart.1780230510">10.1002/art.1780230510</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7378088">7378088</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Preliminary+criteria+for+the+classification+of+systemic+sclerosis+%28scleroderma%29.+Subcommittee+for+scleroderma+criteria+of+the+American+Rheumatism+Association+Diagnostic+and+Therapeutic+Criteria+Committee&amp;rft.date=1980&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fart.1780230510&amp;rft_id=info%3Apmid%2F7378088&amp;rft.issue=5&amp;rft.jtitle=Arthritis+Rheum.&amp;rft.pages=581-90&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span> Available online at <span class="citation web"><a rel="nofollow" class="external text" href="http://www.rheumatology.org/publications/classification/systsclr.asp">"1980 Criteria for the Classification of Systemic Sclerosis"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2007-08-05</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.btitle=1980+Criteria+for+the+Classification+of+Systemic+Sclerosis&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.rheumatology.org%2Fpublications%2Fclassification%2Fsystsclr.asp&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><span class="citation journal">Moenning R and Grau RG (March 30, 2009). <a rel="nofollow" class="external text" href="http://jmm.consultantlive.com/display/article/1145622/1391088">"Skin hardening, but is it systemic sclerosis?"</a>. <i>The Journal of Musculoskeletal Medicine</i>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Skin+hardening%2C+but+is+it+systemic+sclerosis%3F&amp;rft.aulast=Moenning+R+and+Grau+RG&amp;rft.au=Moenning+R+and+Grau+RG&amp;rft.date=March+30%2C+2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fjmm.consultantlive.com%2Fdisplay%2Farticle%2F1145622%2F1391088&amp;rft.jtitle=The+Journal+of+Musculoskeletal+Medicine&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.ncbi.nlm.nih.gov/pubmed/10609071">http://www.ncbi.nlm.nih.gov/pubmed/10609071</a></span></li>
<li id="cite_note-Bianchi-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-Bianchi_25-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Bianchi DW (2000). "Fetomaternal cell trafficking: a new cause of disease?". <i>Am. J. Med. Genet.</i> <b>91</b> (1): 22–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F%28SICI%291096-8628%2820000306%2991%3A1%3C22%3A%3AAID-AJMG4%3E3.0.CO%3B2-3">10.1002/(SICI)1096-8628(20000306)91:1&lt;22::AID-AJMG4&gt;3.0.CO;2-3</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10751084">10751084</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Fetomaternal+cell+trafficking%3A+a+new+cause+of+disease%3F&amp;rft.au=Bianchi+DW&amp;rft.aulast=Bianchi+DW&amp;rft.date=2000&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F%28SICI%291096-8628%2820000306%2991%3A1%3C22%3A%3AAID-AJMG4%3E3.0.CO%3B2-3&amp;rft_id=info%3Apmid%2F10751084&amp;rft.issue=1&amp;rft.jtitle=Am.+J.+Med.+Genet.&amp;rft.pages=22-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=91" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20299369-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20299369_26-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Abdel-Kader K, Patel PR, Kallen AJ, Sinkowitz-Cochran RL, Bolton WK, Unruh ML (March 2010). <a rel="nofollow" class="external text" href="http://cjasn.asnjournals.org/cgi/pmidlookup?view=long&amp;pmid=20299369">"Nephrogenic Systemic Fibrosis: A Survey of Nephrologists' Perceptions and Practices"</a>. <i>Clin J Am Soc Nephrol</i> <b>5</b> (6): 964–71. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2215%2FCJN.00140110">10.2215/CJN.00140110</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2879309">2879309</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20299369">20299369</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Nephrogenic+Systemic+Fibrosis%3A+A+Survey+of+Nephrologists%27+Perceptions+and+Practices&amp;rft.au=Abdel-Kader+K%2C+Patel+PR%2C+Kallen+AJ%2C+Sinkowitz-Cochran+RL%2C+Bolton+WK%2C+Unruh+ML&amp;rft.aulast=Abdel-Kader+K%2C+Patel+PR%2C+Kallen+AJ%2C+Sinkowitz-Cochran+RL%2C+Bolton+WK%2C+Unruh+ML&amp;rft.date=March+2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcjasn.asnjournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D20299369&amp;rft_id=info%3Adoi%2F10.2215%2FCJN.00140110&amp;rft_id=info%3Apmc%2F2879309&amp;rft_id=info%3Apmid%2F20299369&amp;rft.issue=6&amp;rft.jtitle=Clin+J+Am+Soc+Nephrol&amp;rft.pages=964-71&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20120045-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20120045_27-0">^</a></b></span> <span class="reference-text"><span class="citation journal">"[Nephrogenic systemic fibrosis or kidney failure--how great is the risk?]". <i>Rofo</i> (in German) <b>182</b> (2): 114–5. February 2010. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20120045">20120045</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=%5BNephrogenic+systemic+fibrosis+or+kidney+failure--how+great+is+the+risk%3F%5D&amp;rft.date=February+2010&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F20120045&amp;rft.issue=2&amp;rft.jtitle=Rofo&amp;rft.pages=114-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=182" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20118047-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20118047_28-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Panos A, Milas F, Kalakonas S, Myers PO (2010). <a rel="nofollow" class="external text" href="http://www.hellenicjcardiol.org/archive/full_text/2010/1/2010_1_64.pdf">"Cardiac autotransplantation for aortic and mitral valve replacement in a patient with nephrogenic systemic fibrosis"</a> <span style="font-size:85%;">(PDF)</span>. <i>Hellenic J Cardiol</i> <b>51</b> (1): 64–6. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20118047">20118047</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Cardiac+autotransplantation+for+aortic+and+mitral+valve+replacement+in+a+patient+with+nephrogenic+systemic+fibrosis&amp;rft.aulast=Panos+A%2C+Milas+F%2C+Kalakonas+S%2C+Myers+PO&amp;rft.au=Panos+A%2C+Milas+F%2C+Kalakonas+S%2C+Myers+PO&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.hellenicjcardiol.org%2Farchive%2Ffull_text%2F2010%2F1%2F2010_1_64.pdf&amp;rft_id=info%3Apmid%2F20118047&amp;rft.issue=1&amp;rft.jtitle=Hellenic+J+Cardiol&amp;rft.pages=64-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=51" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20063400-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20063400_29-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Fine DM, Perazella MA (January 2010). "Nephrogenic systemic fibrosis: what the hospitalist needs to know". <i>J Hosp Med</i> <b>5</b> (1): 46–50. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fjhm.493">10.1002/jhm.493</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20063400">20063400</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Nephrogenic+systemic+fibrosis%3A+what+the+hospitalist+needs+to+know&amp;rft.au=Fine+DM%2C+Perazella+MA&amp;rft.aulast=Fine+DM%2C+Perazella+MA&amp;rft.date=January+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fjhm.493&amp;rft_id=info%3Apmid%2F20063400&amp;rft.issue=1&amp;rft.jtitle=J+Hosp+Med&amp;rft.pages=46-50&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><span class="citation journal">Boyd AS, Zic JA, Abraham JL (2007). "Gadolinium deposition in nephrogenic fibrosing dermopathy". <i>J. Am. Acad. Dermatol.</i> <b>56</b> (1): 27–30. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.jaad.2006.10.048">10.1016/j.jaad.2006.10.048</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17109993">17109993</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Gadolinium+deposition+in+nephrogenic+fibrosing+dermopathy&amp;rft.au=Boyd+AS%2C+Zic+JA%2C+Abraham+JL&amp;rft.aulast=Boyd+AS%2C+Zic+JA%2C+Abraham+JL&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jaad.2006.10.048&amp;rft_id=info%3Apmid%2F17109993&amp;rft.issue=1&amp;rft.jtitle=J.+Am.+Acad.+Dermatol.&amp;rft.pages=27-30&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=56" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-31">^</a></b></span> <span class="reference-text"><span class="citation journal">Sharma SK, Handa R, Sood R et al. (2004). "Bleomycin-induced scleroderma". <i>The Journal of the Association of Physicians of India</i> <b>52</b>: 76–7. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15633728">15633728</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Bleomycin-induced+scleroderma&amp;rft.aulast=Sharma+SK%2C+Handa+R%2C+Sood+R&amp;rft.au=Sharma+SK%2C+Handa+R%2C+Sood+R&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F15633728&amp;rft.jtitle=The+Journal+of+the+Association+of+Physicians+of+India&amp;rft.pages=76-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=52" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><span class="citation journal">Farrant PB, Mortimer PS, Gore M (2004). "Scleroderma and the taxanes. Is there really a link?". <i>Clin. Exp. Dermatol.</i> <b>29</b> (4): 360–2. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1365-2230.2004.01519.x">10.1111/j.1365-2230.2004.01519.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15245529">15245529</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Scleroderma+and+the+taxanes.+Is+there+really+a+link%3F&amp;rft.au=Farrant+PB%2C+Mortimer+PS%2C+Gore+M&amp;rft.aulast=Farrant+PB%2C+Mortimer+PS%2C+Gore+M&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2230.2004.01519.x&amp;rft_id=info%3Apmid%2F15245529&amp;rft.issue=4&amp;rft.jtitle=Clin.+Exp.+Dermatol.&amp;rft.pages=360-2&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=29" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><span class="citation journal">Kettaneh A, Al Moufti O, Tiev KP et al. (2007). "Occupational exposure to solvents and gender-related risk of systemic sclerosis: a metaanalysis of case-control studies". <i>J. Rheumatol.</i> <b>34</b> (1): 97–103. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17117485">17117485</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Occupational+exposure+to+solvents+and+gender-related+risk+of+systemic+sclerosis%3A+a+metaanalysis+of+case-control+studies&amp;rft.au=Kettaneh+A%2C+Al+Moufti+O%2C+Tiev+KP&amp;rft.aulast=Kettaneh+A%2C+Al+Moufti+O%2C+Tiev+KP&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F17117485&amp;rft.issue=1&amp;rft.jtitle=J.+Rheumatol.&amp;rft.pages=97-103&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=34" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><span class="citation journal">Fonseca C, Lindahl GE, Ponticos M et al. (September 2007). <a rel="nofollow" class="external text" href="http://content.nejm.org/cgi/content/full/357/12/1210">"A polymorphism in the CTGF promoter region associated with systemic sclerosis"</a>. <i>N. Engl. J. Med.</i> <b>357</b> (12): 1210–20. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMoa067655">10.1056/NEJMoa067655</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17881752">17881752</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=A+polymorphism+in+the+CTGF+promoter+region+associated+with+systemic+sclerosis&amp;rft.au=Fonseca+C%2C+Lindahl+GE%2C+Ponticos+M&amp;rft.aulast=Fonseca+C%2C+Lindahl+GE%2C+Ponticos+M&amp;rft.date=September+2007&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fcontent%2Ffull%2F357%2F12%2F1210&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa067655&amp;rft_id=info%3Apmid%2F17881752&amp;rft.issue=12&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=1210-20&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=357" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-35">^</a></b></span> <span class="reference-text"><span class="citation journal">Oliver GF, Winkelmann RK (1989). "The current treatment of scleroderma". <i>Drugs</i> <b>37</b> (1): 87–96. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2165%2F00003495-198937010-00006">10.2165/00003495-198937010-00006</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2651089">2651089</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=The+current+treatment+of+scleroderma&amp;rft.aulast=Oliver+GF%2C+Winkelmann+RK&amp;rft.au=Oliver+GF%2C+Winkelmann+RK&amp;rft.date=1989&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2165%2F00003495-198937010-00006&amp;rft_id=info%3Apmid%2F2651089&amp;rft.issue=1&amp;rft.jtitle=Drugs&amp;rft.pages=87-96&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=37" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><span class="citation book">Philip J. Clements and Daniel E. Furst. <a rel="nofollow" class="external text" href="http://www.hopkinsscleroderma.org/downloads/SystemicSclerosis_Chapter23.pdf"><i>Systemic Sclerosis, 2nd ed., Chapt. 23</i></a> <span style="font-size:85%;">(PDF)</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.aulast=Philip+J.+Clements+and+Daniel+E.+Furst&amp;rft.au=Philip+J.+Clements+and+Daniel+E.+Furst&amp;rft.btitle=Systemic+Sclerosis%2C+2nd+ed.%2C+Chapt.+23&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.hopkinsscleroderma.org%2Fdownloads%2FSystemicSclerosis_Chapter23.pdf&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Zandberg-37"><span class="mw-cite-backlink">^ <a href="#cite_ref-Zandberg_37-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Zandberg_37-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Zandberg_37-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Zandberg_37-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Zandberg_37-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Zandman-Goddard G, Tweezer-Zaks N, Shoenfeld Y (2005). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2275417">"New therapeutic strategies for systemic sclerosis--a critical analysis of the literature"</a>. <i>Clin. Dev. Immunol.</i> <b>12</b> (3): 165–73. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1080%2F17402520500233437">10.1080/17402520500233437</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2275417">2275417</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16295521">16295521</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=New+therapeutic+strategies+for+systemic+sclerosis--a+critical+analysis+of+the+literature&amp;rft.aulast=Zandman-Goddard+G%2C+Tweezer-Zaks+N%2C+Shoenfeld+Y&amp;rft.au=Zandman-Goddard+G%2C+Tweezer-Zaks+N%2C+Shoenfeld+Y&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2275417&amp;rft_id=info%3Adoi%2F10.1080%2F17402520500233437&amp;rft_id=info%3Apmc%2F2275417&amp;rft_id=info%3Apmid%2F16295521&amp;rft.issue=3&amp;rft.jtitle=Clin.+Dev.+Immunol.&amp;rft.pages=165-73&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=12" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><span class="citation journal">Tashkin DP, Elashoff R, Clements PJ et al. (June 2006). <a rel="nofollow" class="external text" href="http://content.nejm.org/cgi/content/full/354/25/2655">"Cyclophosphamide versus placebo in scleroderma lung disease"</a>. <i>N. Engl. J. Med.</i> <b>354</b> (25): 2655–66. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMoa055120">10.1056/NEJMoa055120</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16790698">16790698</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Cyclophosphamide+versus+placebo+in+scleroderma+lung+disease&amp;rft.aulast=Tashkin+DP%2C+Elashoff+R%2C+Clements+PJ&amp;rft.au=Tashkin+DP%2C+Elashoff+R%2C+Clements+PJ&amp;rft.date=June+2006&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fcontent%2Ffull%2F354%2F25%2F2655&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa055120&amp;rft_id=info%3Apmid%2F16790698&amp;rft.issue=25&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=2655-66&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=354" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><span class="citation journal">Hoyles RK, Ellis RW, Wellsbury J et al. (December 2006). <a rel="nofollow" class="external text" href="http://www3.interscience.wiley.com/cgi-bin/fulltext/113490260/HTMLSTART">"A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma"</a>. <i>Arthritis Rheum.</i> <b>54</b> (12): 3962–70. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fart.22204">10.1002/art.22204</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17133610">17133610</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=A+multicenter%2C+prospective%2C+randomized%2C+double-blind%2C+placebo-controlled+trial+of+corticosteroids+and+intravenous+cyclophosphamide+followed+by+oral+azathioprine+for+the+treatment+of+pulmonary+fibrosis+in+scleroderma&amp;rft.au=Hoyles+RK%2C+Ellis+RW%2C+Wellsbury+J&amp;rft.aulast=Hoyles+RK%2C+Ellis+RW%2C+Wellsbury+J&amp;rft.date=December+2006&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww3.interscience.wiley.com%2Fcgi-bin%2Ffulltext%2F113490260%2FHTMLSTART&amp;rft_id=info%3Adoi%2F10.1002%2Fart.22204&amp;rft_id=info%3Apmid%2F17133610&amp;rft.issue=12&amp;rft.jtitle=Arthritis+Rheum.&amp;rft.pages=3962-70&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=54" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-JAMA2014-editorial-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-JAMA2014-editorial_40-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Dinesh Khanna D, Georges GE, Couriel DR (June 25, 2014). <a rel="nofollow" class="external text" href="http://jama.jamanetwork.com/article.aspx?articleid=1882991">"Autologous Hematopoietic Stem Cell Therapy in Severe Systemic Sclerosis: Ready for Clinical Practice?"</a>. <i>JAMA.</i> <b>311</b> (24): 2485–2487. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Fjama.2014.6369">10.1001/jama.2014.6369</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Autologous+Hematopoietic+Stem+Cell+Therapy+in+Severe+Systemic+Sclerosis%3A+Ready+for+Clinical+Practice%3F&amp;rft.date=June+25%2C+2014&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fjama.jamanetwork.com%2Farticle.aspx%3Farticleid%3D1882991&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2014.6369&amp;rft.issue=24&amp;rft.jtitle=JAMA.&amp;rft.pages=2485-2487.&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=311" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-JAMA2014-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-JAMA2014_41-0">^</a></b></span> <span class="reference-text"><span class="citation journal">van Laar JM, Farge Sont JK, ET AL., for the EBMT/EULAR Scleroderma Study Group (June 25, 2014). <a rel="nofollow" class="external text" href="http://jama.jamanetwork.com/article.aspx?articleid=1883019">"Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis: A Randomized Clinical Trial"</a>. <i>JAMA.</i> <b>311</b> (24): 2490–2498. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Fjama.2014.6368">10.1001/jama.2014.6368</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.atitle=Autologous+Hematopoietic+Stem+Cell+Transplantation+vs+Intravenous+Pulse+Cyclophosphamide+in+Diffuse+Cutaneous+Systemic+Sclerosis%3A+A+Randomized+Clinical+Trial&amp;rft.date=June+25%2C+2014&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fjama.jamanetwork.com%2Farticle.aspx%3Farticleid%3D1883019&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2014.6368&amp;rft.issue=24&amp;rft.jtitle=JAMA.&amp;rft.pages=2490-2498.&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=311" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text">Stem Cell Transplant vs. Cyclophosphamide (SCOT), NCT00114530</span></li>
<li id="cite_note-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-43">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.wrongdiagnosis.com/s/scleroderma/prevalence.htm">WrongDiagnosis &gt; Diseases&#160;» Scleroderma&#160;» Prevalence</a> Retrieved on Dec 13, 2009</span></li>
<li id="cite_note-uptodate-44"><span class="mw-cite-backlink">^ <a href="#cite_ref-uptodate_44-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-uptodate_44-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.uptodate.com/patients/content/topic.do?topicKey=~9I6nAkzrXkEDWZ">Systemic sclerosis (scleroderma) and pregnancy</a> By Bonnie L Bermas, MD. Retrieved on Dec 13, 2009</span></li>
<li id="cite_note-umm-45"><span class="mw-cite-backlink">^ <a href="#cite_ref-umm_45-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-umm_45-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-umm_45-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.umm.edu/patiented/articles/who_gets_scleroderma_000088_4.htm">University of maryland Medical Center &gt; Medical Reference &gt; Patient Education &gt; Scleroderma - Risk Factors</a> Harvey Simon, MD, Reviewed last on: 3/17/2009</span></li>
<li id="cite_note-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-46">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.cureresearch.com/s/scleroderma/prevalence.htm">CureResearch &gt; Prevalence and Incidence of Scleroderma</a> Last revision: June 13, 2003</span></li>
<li id="cite_note-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-47">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.jsdn.org/">"Juvenile Scleroderma Network"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-05-11</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.btitle=Juvenile+Scleroderma+Network&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.jsdn.org%2F&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.scleroderma.org/">"Scleroderma Foundation"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-05-11</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.btitle=Scleroderma+Foundation&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.scleroderma.org%2F&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.srfcure.org">"Scleroderma Research Foundation"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-05-11</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASystemic+scleroderma&amp;rft.btitle=Scleroderma+Research+Foundation&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.srfcure.org&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span>.</span></li>
<li id="cite_note-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-50">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.imdb.com/title/tt0116335/"><i>For Hope</i></a> at the <a href="/wiki/Internet_Movie_Database" title="Internet Movie Database">Internet Movie Database</a></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Systemic_scleroderma&amp;action=edit&amp;section=15" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a rel="nofollow" class="external text" href="http://www.raynauds.org.uk/">UK Raynaud's &amp; Scleroderma Association</a></li>
<li><a rel="nofollow" class="external text" href="http://dermnetnz.org/immune/systemic-sclerosis.html">DermnetNZ: Systemic sclerosis</a></li>
<li><a rel="nofollow" class="external text" href="http://www.jsdn.org/">Juvenile Scleroderma Network</a></li>
<li><a rel="nofollow" class="external text" href="http://www.juvenile-scleroderma.com/">Juvenile Systemic Sclerosis</a></li>
<li><a rel="nofollow" class="external text" href="http://www.scleroderma.org/">Scleroderma Foundation</a></li>
<li><a rel="nofollow" class="external text" href="http://www.sclerodermaontario.ca/">Scleroderma Society of Ontario</a></li>
<li><a rel="nofollow" class="external text" href="http://www.sclero.org/index.html">International Scleroderma Network</a></li>
<li><a rel="nofollow" class="external text" href="http://www.sclerodermaresearch.org/">The Scleroderma Research Foundation</a></li>
<li><a rel="nofollow" class="external text" href="http://www.sclerodermasociety.co.uk/">UK Scleroderma Society</a></li>
<li><a rel="nofollow" class="external text" href="http://scleroderma.jhmi.edu/">Scleroderma Information from Johns Hopkins University</a></li>
<li><a rel="nofollow" class="external text" href="http://www.sclerodermaaustralia.com.au/">Scleroderma Australia</a></li>
</ul>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Systemic_connective_tissue_disorders" title="Template:Systemic connective tissue disorders"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Systemic_connective_tissue_disorders" title="Template talk:Systemic connective tissue disorders"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Systemic_connective_tissue_disorders&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Systemic <a href="/wiki/Connective_tissue_disease" title="Connective tissue disease">connective tissue disorders</a> (<a href="/wiki/ICD-10_Chapter_XIII:_Diseases_of_the_musculoskeletal_system_and_connective_tissue#.28M30.E2.80.93M36.29_Systemic_connective_tissue_disorders" title="ICD-10 Chapter XIII: Diseases of the musculoskeletal system and connective tissue">M32–M36</a>, <a href="/wiki/List_of_ICD-9_codes_710%E2%80%93739:_diseases_of_the_musculoskeletal_system_and_connective_tissue" title="List of ICD-9 codes 710–739: diseases of the musculoskeletal system and connective tissue">710</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">General</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Systemic_lupus_erythematosus" title="Systemic lupus erythematosus">Systemic lupus erythematosus</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Drug-induced_lupus_erythematosus" title="Drug-induced lupus erythematosus">Drug-induced SLE</a></li>
<li><a href="/wiki/Libman%E2%80%93Sacks_endocarditis" title="Libman–Sacks endocarditis">Libman-Sacks endocarditis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Inflammatory_myopathy" title="Inflammatory myopathy">Inflammatory myopathy</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Myositis" title="Myositis">Myositis</a></li>
<li><a href="/wiki/Dermatopolymyositis" title="Dermatopolymyositis">Dermatopolymyositis</a>
<ul>
<li><a href="/wiki/Dermatomyositis" title="Dermatomyositis">Dermatomyositis</a>/<a href="/wiki/Juvenile_dermatomyositis" title="Juvenile dermatomyositis">Juvenile dermatomyositis</a></li>
<li><a href="/wiki/Polymyositis" title="Polymyositis">Polymyositis</a>* <a href="/wiki/Inclusion_body_myositis" title="Inclusion body myositis">Inclusion body myositis</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Scleroderma" title="Scleroderma">Scleroderma</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><strong class="selflink">Systemic scleroderma</strong>
<ul>
<li><a href="/wiki/Progressive_systemic_sclerosis" title="Progressive systemic sclerosis">Progressive systemic sclerosis</a></li>
<li><a href="/wiki/CREST_syndrome" title="CREST syndrome">CREST syndrome</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Overlap_syndrome" title="Overlap syndrome">Overlap syndrome</a> / <a href="/wiki/Mixed_connective_tissue_disease" title="Mixed connective tissue disease">Mixed connective tissue disease</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other <a href="/wiki/Hypersensitivity" title="Hypersensitivity">hypersensitivity</a>/<a href="/wiki/Autoimmune_disease" title="Autoimmune disease">autoimmune</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Sj%C3%B6gren%27s_syndrome" title="Sjögren's syndrome">Sjögren's syndrome</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Beh%C3%A7et%27s_disease" title="Behçet's disease">Behçet's disease</a></li>
<li><a href="/wiki/Polymyalgia_rheumatica" title="Polymyalgia rheumatica">Polymyalgia rheumatica</a></li>
<li><a href="/wiki/Eosinophilic_fasciitis" title="Eosinophilic fasciitis">Eosinophilic fasciitis</a></li>
<li><a href="/wiki/Eosinophilia%E2%80%93myalgia_syndrome" title="Eosinophilia–myalgia syndrome">Eosinophilia–myalgia syndrome</a></li>
<li><a href="/wiki/Fibrillin" title="Fibrillin">fibrillin</a>
<ul>
<li><a href="/wiki/Marfan_syndrome" title="Marfan syndrome">Marfan syndrome</a></li>
<li><a href="/wiki/Congenital_contractural_arachnodactyly" title="Congenital contractural arachnodactyly">Congenital contractural arachnodactyly</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Muscle_navs" title="Template:Muscle navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Muscle_navs" title="Template talk:Muscle navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Muscle_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Muscle" title="Muscle">muscle</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Muscular_system" title="Template:Muscular system">Anatomy</a>
<ul>
<li><a href="/wiki/Template:Muscles_of_head" title="Template:Muscles of head">head</a></li>
<li><a href="/wiki/Template:Muscles_of_neck" title="Template:Muscles of neck">neck</a></li>
<li><a href="/wiki/Template:Muscles_of_upper_limb" title="Template:Muscles of upper limb">arms</a></li>
<li><a href="/wiki/Template:Muscles_of_thorax_and_back" title="Template:Muscles of thorax and back">chest and back</a></li>
<li><a href="/wiki/Template:Thoracic_diaphragm" title="Template:Thoracic diaphragm">diaphragm</a></li>
<li><a href="/wiki/Template:Muscles_of_abdomen" title="Template:Muscles of abdomen">abdomen</a></li>
<li><a href="/wiki/Template:Muscles_of_perineum" title="Template:Muscles of perineum">genital area</a></li>
<li><a href="/wiki/Template:Muscles_of_lower_limb" title="Template:Muscles of lower limb">legs</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Muscle_tissue" title="Template:Muscle tissue">Muscle tissue</a></li>
<li><a href="/wiki/Template:Muscular_physiology" title="Template:Muscular physiology">Physiology</a>
<ul>
<li><a href="/wiki/Template:Connective_tissue" title="Template:Connective tissue">connective tissue</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Myopathy" title="Template:Myopathy">Myopathy</a></li>
<li><a href="/wiki/Template:Soft_tissue_disorders" title="Template:Soft tissue disorders">Soft tissue</a></li>
<li><a href="/wiki/Template:Systemic_connective_tissue_disorders" title="Template:Systemic connective tissue disorders">Connective tissue</a></li>
<li><a href="/wiki/Template:Diseases_of_myoneural_junction_and_muscle" title="Template:Diseases of myoneural junction and muscle">Congenital</a>
<ul>
<li><a href="/wiki/Template:Congenital_diaphragm_and_abdominal_wall_defects" title="Template:Congenital diaphragm and abdominal wall defects">abdomen</a></li>
<li><a href="/wiki/Template:Muscular_dystrophy" title="Template:Muscular dystrophy">muscular dystrophy</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Soft_tissue_tumors_and_sarcomas" title="Template:Soft tissue tumors and sarcomas">Neoplasms and cancer</a></li>
<li><a href="/wiki/Template:Dislocations,_sprains_and_strains" title="Template:Dislocations, sprains and strains">Injury</a></li>
<li><a href="/wiki/Template:Nervous_and_musculoskeletal_system_symptoms_and_signs" title="Template:Nervous and musculoskeletal system symptoms and signs">Symptoms and signs</a>
<ul>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_muscles_and_soft_tissue" title="Template:Eponymous medical signs for muscles and soft tissue">eponymous</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Muscle_and_soft_tissue_procedures" title="Template:Muscle and soft tissue procedures">Procedures</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Anti-inflammatory_products" title="Template:Anti-inflammatory products">anti-inflammatory</a></li>
<li><a href="/wiki/Template:Muscle_relaxants" title="Template:Muscle relaxants">muscle relaxants</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1181
CPU time usage: 0.536 seconds
Real time usage: 0.622 seconds
Preprocessor visited node count: 3563/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 131532/2097152 bytes
Template argument size: 2085/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 3/500
Lua time usage: 0.190/10.000 seconds
Lua memory usage: 4.08 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00%  496.286      1 - -total
 51.22%  254.217      1 - Template:Reflist
 23.81%  118.160     36 - Template:Cite_journal
 16.20%   80.412      1 - Template:Infobox_disease
 13.83%   68.654      1 - Template:Infobox
  8.59%   42.607      3 - Template:Navbox
  7.55%   37.469      3 - Template:Fix
  7.17%   35.603      1 - Template:MEDRS
  7.15%   35.460      1 - Template:Systemic_connective_tissue_disorders
  6.56%   32.539      5 - Template:Category_handler
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:26951-0!*!0!!en!4!* and timestamp 20150711093109 and revision id 653035090
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Systemic_scleroderma&amp;oldid=653035090">https://en.wikipedia.org/w/index.php?title=Systemic_scleroderma&amp;oldid=653035090</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Mucinoses" title="Category:Mucinoses">Mucinoses</a></li><li><a href="/wiki/Category:Connective_tissue_diseases" title="Category:Connective tissue diseases">Connective tissue diseases</a></li><li><a href="/wiki/Category:Autoimmune_diseases" title="Category:Autoimmune diseases">Autoimmune diseases</a></li><li><a href="/wiki/Category:Disorders_of_fascia" title="Category:Disorders of fascia">Disorders of fascia</a></li><li><a href="/wiki/Category:Systemic_connective_tissue_disorders" title="Category:Systemic connective tissue disorders">Systemic connective tissue disorders</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">CS1 maint: Explicit use of et al.</a></li><li><a href="/wiki/Category:CS1_German-language_sources_(de)" title="Category:CS1 German-language sources (de)">CS1 German-language sources (de)</a></li><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:All_articles_lacking_reliable_references" title="Category:All articles lacking reliable references">All articles lacking reliable references</a></li><li><a href="/wiki/Category:Articles_lacking_reliable_references_from_November_2014" title="Category:Articles lacking reliable references from November 2014">Articles lacking reliable references from November 2014</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_May_2008" title="Category:Articles with unsourced statements from May 2008">Articles with unsourced statements from May 2008</a></li><li><a href="/wiki/Category:Articles_with_limited_geographic_scope_from_May_2008" title="Category:Articles with limited geographic scope from May 2008">Articles with limited geographic scope from May 2008</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Systemic+scleroderma&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Systemic+scleroderma" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Systemic_scleroderma"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Systemic_scleroderma"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Systemic_scleroderma" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Systemic_scleroderma&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Systemic_scleroderma&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Systemic_scleroderma" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Systemic_scleroderma" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Systemic_scleroderma&amp;oldid=653035090" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Systemic_scleroderma&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q5340515" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Systemic_scleroderma&amp;id=653035090" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Systemic+scleroderma">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Systemic+scleroderma&amp;oldid=653035090&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Systemic_scleroderma&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Scl%C3%A9rodermie_syst%C3%A9mique" title="Sclérodermie systémique – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-hy"><a href="//hy.wikipedia.org/wiki/%D4%BF%D5%A1%D6%80%D5%AE%D6%80%D5%A1%D5%B4%D5%A1%D5%B7%D5%AF%D5%B8%D6%82%D5%A9%D5%B5%D5%B8%D6%82%D5%B6" title="Կարծրամաշկություն – Armenian" lang="hy" hreflang="hy">Հայերեն</a></li><li class="interlanguage-link interwiki-no"><a href="//no.wikipedia.org/wiki/Systemisk_sklerose" title="Systemisk sklerose – Norwegian" lang="no" hreflang="no">Norsk bokmål</a></li><li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%A1%D0%B8%D1%81%D1%82%D0%B5%D0%BC%D0%BD%D0%B0%D1%8F_%D1%81%D0%BA%D0%BB%D0%B5%D1%80%D0%BE%D0%B4%D0%B5%D1%80%D0%BC%D0%B8%D1%8F" title="Системная склеродермия – Russian" lang="ru" hreflang="ru">Русский</a></li><li class="interlanguage-link interwiki-sr"><a href="//sr.wikipedia.org/wiki/Sistemska_skleroza" title="Sistemska skleroza – Serbian" lang="sr" hreflang="sr">Српски / srpski</a></li><li class="interlanguage-link interwiki-uk"><a href="//uk.wikipedia.org/wiki/%D0%A1%D0%B8%D1%81%D1%82%D0%B5%D0%BC%D0%BD%D0%B0_%D1%81%D0%BA%D0%BB%D0%B5%D1%80%D0%BE%D0%B4%D0%B5%D1%80%D0%BC%D1%96%D1%8F" title="Системна склеродермія – Ukrainian" lang="uk" hreflang="uk">Українська</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q5340515#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 22 March 2015, at 17:08.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Systemic_scleroderma&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":107,"wgHostname":"mw1045"});
}</script>
	</body>
</html>
